LIPELLA PHARMACEUTICALS INC. (CIK 1347242, LIPO) reported 2 filings on its bankruptcy or receivership to the SEC on Form 8-K under Item 1.03, the latest filed 2026-07-15. The sentences below are quoted from the filings as written.
The filings
Form 8-K filed 2026-07-15 · Chapter 11
The petition
Asset Purchase Agreement On March 30, 2026, Lipella Pharmaceuticals Inc. (the "Company") filed a voluntary petition for relief under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the "Bankruptcy Court") at Case No. 26-20879-CMB (the "Bankruptcy Case").
Form 8-K filed 2026-03-31 · Chapter 11
The petition
On [Filing Date] , [Company Name, Inc.] (the "Company") and certain of its subsidiaries (collectively, the "Debtors") filed voluntary petitions for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Western District of Pennsylvania (the "Bankruptcy Court").
Where this comes from
Public companies report a bankruptcy, a receivership or a similar proceeding to the SEC on Form 8-K under Item 1.03, usually within four business days. Every filing listed here is one of them, linked to the filing itself. The sentences shown are quoted from the filing exactly; where a filing does not state the court, the case or the chapter in one sentence, nothing is shown in its place.
The state is where the company says its business is, and the industry is the one it registered with the SEC. A filing reports what the company filed; it does not say whether creditors will be paid, and neither does this page.
All recent bankruptcy filingsThat week
Cite this page
https://mentionfox.com/bankruptcy/lipella-pharmaceuticals